Effect of Monensin on Cow Health and Milk Production in Early Lactation

Authors

  • T. F. Duffield Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • K. E. Leslie Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • D. Sandals Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • K. Lissemore Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • B. McBride Department of Animal & Poultry Science, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • J. H. Lumsden Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1

DOI:

https://doi.org/10.21423/aabppro19975877

Keywords:

monensin, periparturient disease, milk production

Abstract

Dry cows and springing heifers from twenty-five farms near Guelph, Ontario, Canada were enrolled in a large double blinded and randomized clinical trial designed to evaluate the impact of monensin on periparturient disease and milk production. A total of 503 cows were given monensin controlled release capsules and 507 animals were administered placebo capsules three weeks prior to expected calving date.

Cover image of the 30th Conference Proceedings: A photo of skyscrapers in Montreal. Yellow background.

Downloads

Published

1997-09-18

Issue

1997

Section

Research Summaries - Dairy I & II

Most read articles by the same author(s)

1 2 3 4 5 > >>